Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Strides Pharma Science has informed it enclosed the link of audio recording of earnings call pertaining to the financial results of the company for the quarter and nine months ended December 31, 2022 held on Tuesday, January 24, 2023. The Results were approved by the Board at its meeting held on January 24, 2023. The same can also be accessed on the Company’s website at: https://www.strides.com/investor-annualreport.html.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: